Ligand · 3IF
3IF · N-[(3S)-7-(2-cyclopropylethynyl)-5-methyl-4-oxidanylidene-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-(phenylmethyl)-4H-1,2,4-triazole-3-carboxamide
3IF, N-[(3S)-7-(2-cyclopropylethynyl)-5-methyl-4-oxidanylidene-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-(phenylmethyl)-4H-1,2,4-triazole-3-carboxamide (C25 H23 N5 O3, 441.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1…
- Component
- 3IF
- Formula
- C25 H23 N5 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
3IF in 2 structures; the first of them:
- 7FCZ · Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor · 3IF A301 · binds VAL31, ILE43, MET44, LYS45, MET67, LEU70, VAL75, VAL76 and 15 more
- 7FCZ · Crystal structure of human RIPK1 kinase domain in complex with a novel inhibitor · 3IF A301 · binds VAL31, ILE43, LYS45, MET67, LEU70, VAL75, VAL76, LEU78 and 12 more
Residues it binds most
LEU 4, VAL 4, MET 4, ILE 4, LYS 4, PHE 4, ALA 4, ASP 4, HIS 4, SER 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.